Md. Abdullah Al Noman Email and Phone Number
Optimistic and a firm believer in the power of strategic planning and smart work - that's me! I thrive in both independent and collaborative environments, striving to serve as the guiding light of a strong team. In addition to being a lifelong learner, I am a passionate listener, eager to learn (one new thing every day!). Outside of the workplace, I enjoy traveling, listening to music, reading books, and watching movies. Continuous learning and professional development are important to me, and I actively seek out opportunities to expand my knowledge in the field of oncology.My Journey at Beacon Pharmaceuticals PLC:At Beacon Pharmaceuticals PLC, a leading Bangladeshi manufacturer of anticancer drugs, I have been working in the Oncology Department since February 2018. As Assistant Manager, I oversee a variety of immunotherapies, targeted therapies, and other critical medications. In addition, I am active in departmental strategic initiatives and systemic development initiatives.Key Achievements:-Successfully led the launch of Bangladesh's first immunotherapy (Pembrolizumab) in March 2021, marking a significant milestone in cancer treatment accessibility.-Introduced the first FDA-approved PARP inhibitor to local patients, expanding treatment options.-Played a key role in relaunching and repositioning products within the department.-Managed national conferences and participated in international oncology events, contributing to knowledge exchange and professional development.I look forward to collaborating with professionals within the oncology field and discussing advancements in cancer treatment.
-
Assistant ManagerBeacon Pharmaceuticals LimitedDhaka, Bd -
Assistant ManagerBeacon Pharmaceuticals Limited Jan 2023 - PresentDhaka, Bangladesh## Current Responsibilities- Working on the business expansion for Immunotherapy portfolio- Building and maintaining professional relationship with KOLs regarding their research & publications- Managing two team members who are looking after Colorectal Cancer Portfolio and Midriff Cancers Portfolio -
Junior Assistant ManagerBeacon Pharmaceuticals Limited Jan 2022 - Dec 2022Bangladesh## Immunotherapy PortfolioIn 2022 I have been promoted as Jr. Asst. Manager to develop and expand a new market segment, IMMUNOTHERAPY, in oncology sector. Currently this portfolio consists of two biosimilar, immune checkpoint inhibitor molecules- Pembrolizumab (PEMRO) and Nivolumab (NIVOMAB).## Current Responsibilities- Developing and implementing new strategies to create new prescribers for Immunotherapy- C2C communications to analyze the positioning of the molecules and feedbacks of efficacies- Developing new product pipeline to enlarge the portfolio- Besides got a team member to manage who is looking after my previous portfolio -
Senior Product Executive (Oncology)Beacon Pharmaceuticals Limited Jan 2020 - Dec 2021Dhaka## Managed Molecules:Gemcitabine (Gemoxen), Pembrolizumab (Pemro), Nab-Paclitaxel (Nab-Xelpac), Olaparib (Olapar), Bicalutamide (Bical), Anastrozole (Anastrol), Letrozol (Lexel), Tamoxifen (Tamoxi). The portfolio was consisted with a conventional chemotherapy- Gemcitabine and few other hormone therapies for cancer treatment. Major brand was Gemoxen (Gemcitabine), Pemro (Pembrolizumab).## Achievements- Added values to Gemoxen for ensuring patient benefit and to keep the brand vibrant in the market.- Gemoxen still was the number #1 brand in Gemcitabine market by competing with originator and generic brands by confirming 50% market share (2020-2021).- In 2020 I had launched the 1st ever PARP Inhibitor Olaparib in Bangladesh market in the brand name of Olapar. This molecule has vital roles in Ovarian Cancer, Pancreatic Cancer and Breast Cancer.- Nab-Xelpac, the choice of molecule for Triple Negative Breast Cancer (TNBC), was added to my portfolio in 2021 for brand development. Within 2022 Nab-Xelpac had observed a 50% market growth and KBL number was increased from 10 to 30.- 2021 was a remarkable year. In the history of Bangladesh cancer market a revolution was made on this year. A new treatment, IMMUNOTHERAPY, was launched on 26 March 2021 on the eve of 50th Independence Day of Bangladesh. For the first time I had launched generic, biosimilar, bilogical molecules PEMBROLIZUMAB (Pemro) and NIVOLUMAB (Nivomab) in Bangladesh market. -
Executive (Oncology)Beacon Pharmaceuticals Limited Feb 2018 - Dec 2019Dhaka## Managed Molecules:Gemcitabine (Gemoxen), Bicalutamide (Bical), Anastrozole (Anastrol), Letrozol (Lexel), Tamoxifen (Tamoxi). The portfolio was consisted with a conventional chemotherapy- Gemcitabine and few other hormone therapies for cancer treatment. Major brand was Gemoxen (Gemcitabine).## Achievements:- Building Gemoxen as a trusted and 1st choice of brand in prescriptions.- Under my management Gemoxen had 60% market share (2018-2019).- Being the major market share holder Gemoxen was in the leading position of Gemcitabine market.- Gemoxen was the 2nd leading brand of Beacon Oncology.## International Conferences- In 2018 attended 13th Scientific Conference of SAARC Federation of Oncologists (SFO) in Bhutan- In 2019 attended 4th Annual Meeting of Federation of Asian Organization for Radiation Oncologists (FARO) in China -
Research StudentNorth South University Aug 2016 - Aug 2017Dhaka
Md. Abdullah Al Noman Education Details
-
Pharmacology And Clinical Pharmacy -
Pharmaceutical Sciences -
Motijheel Model High SchoolScience
Frequently Asked Questions about Md. Abdullah Al Noman
What company does Md. Abdullah Al Noman work for?
Md. Abdullah Al Noman works for Beacon Pharmaceuticals Limited
What is Md. Abdullah Al Noman's role at the current company?
Md. Abdullah Al Noman's current role is Assistant Manager.
What schools did Md. Abdullah Al Noman attend?
Md. Abdullah Al Noman attended North South University, North South University, Birshreshtha Noor Mohammad Public College Bnmpc, Motijheel Model High School.
Not the Md. Abdullah Al Noman you were looking for?
-
Md. Abdullah Al Noman
Financial Planning & Reporting | Islamic Finance | Venture Capital Fund | Ca - Professional LevelDhaka, Bangladesh -
Md. Abdullah Al Noman
Information Technology & Cybersecurity Executive At Sebpo | Tech EnthusiastDhaka, Bangladesh -
1gmail.com
-
Md. Abdullah Al Noman
Deputy Director (Planning & Development) At Dhaka University Of Engineering & TechnologyBangladesh
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial